![]()
|
|
||||||||
J. Biol. Chem., Vol. 265, Issue 25, 14777-14783, Sep, 1990
R Yamamoto-Honda, O Koshio, K Tobe, Y Shibasaki, K Momomura, M Odawara, T Kadowaki, F Takaku, Y Akanuma and M Kasuga
Institute for Diabetes Care and Research, Asahi Life Foundation, Tokyo, Japan.
Chinese hamster ovary (CHO) cell transfectants that expressed human insulin receptors whose glycine 996 was substituted by valine were studied. Receptor processing and insulin binding were unaffected by this mutation; however, this mutant insulin receptor had little or no tyrosine kinase activity. Nevertheless, the Val996 mutant exhibited seryl and threonyl phosphorylation in both the basal and insulin- stimulated state in intact cells. This is in contrast to the Lys---- Ala1018 tyrosine kinase deficient mutant (Russell, D. S., Gherzi, R., Johnson, E. L., Chou, C-K., and Rosen, O. M. (1987) J. Biol. Chem. 262, 11833-11840). Cells expressing the normal human receptor were 10-fold more sensitive to insulin than the untransfected CHO cells with respect to phosphorylation of a cellular substrate (pp 185) on tyrosyl residues, glucose incorporation into glycogen, thymidine incorporation into DNA, and phosphorylation of ribosomal protein S6. Cells expressing the mutant receptor exhibited the same insulin sensitivity as the untransfected CHO cells. Insulin was rapidly internalized in cells expressing the normal human receptor and the number of receptors expressed on the cell surface was decreased in response to exposure to insulin. However, little insulin was internalized in cells expressing the mutant receptor, and the number of receptors on the cell surface was not significantly diminished in response to exposure to insulin. It is concluded that despite the occurrence of seryl and threonyl phosphorylations, post-receptor effects of insulin described above are not mediated by the tyrosine kinase-deficient receptor, Val996.
This article has been cited by other articles:
![]() |
Z. Zhang, K. Shen, W. Lu, and P. A. Cole The Role of C-terminal Tyrosine Phosphorylation in the Regulation of SHP-1 Explored via Expressed Protein Ligation J. Biol. Chem., February 7, 2003; 278(7): 4668 - 4674. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nakae, M. Kato, M. Murashita, N. Shinohara, T. Tajima, and K. Fujieda Long-Term Effect of Recombinant Human Insulin-Like Growth Factor I on Metabolic and Growth Control in a Patient with Leprechaunism J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 542 - 549. [Abstract] [Full Text] |
||||
![]() |
R. Yamamoto-Honda, K. Tobe, Y. Kaburagi, K. Ueki, S. Asai, M. Yachi, M. Shirouzu, J. Yodoi, Y. Akanuma, S. Yokoyama, et al. Upstream Mechanisms of Glycogen Synthase Activation by Insulin and Insulin-like Growth Factor-I J. Biol. Chem., February 10, 1995; 270(6): 2729 - 2734. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |